Overview
French investment manager with a dedicated senior-housing investment business, alongside private equity and other alternative assets. Its longevity relevance is age-friendly housing rather than a specialist biotechnology strategy.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.